Melachroinou Katerina, Leandrou Emmanouela, Valkimadi Polytimi-Eleni, Memou Anna, Hadjigeorgiou Georgios, Stefanis Leonidas, Rideout Hardy J
Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Department of Neurogenetics, Institute of Biomedical Research & Technology (CERETETH), Larissa, Greece.
PLoS One. 2016 Nov 10;11(11):e0166053. doi: 10.1371/journal.pone.0166053. eCollection 2016.
Despite the plethora of sequence variants in LRRK2, only a few clearly segregate with PD. Even within this group of pathogenic mutations, the phenotypic profile can differ widely.
We examined multiple properties of LRRK2 behavior in cellular models over-expressing three sequence variants described in Greek PD patients in comparison to several known pathogenic and non-pathogenic LRRK2 mutations, to determine if specific phenotypes associated with pathogenic LRRK2 can be observed in other less-common sequence variants for which pathogenicity is unclear based on clinical and/or genetic data alone.
The oligomerization, activity, phosphorylation, and interaction with FADD was assessed in HEK293T cells over-expressing LRRK2; while the induction of neuronal death was determined by quantifying apoptotic nuclei in primary neurons transiently expressing LRRK2.
One LRRK2 variant, A211V, exhibited a modest increase in kinase activity, whereas only the pathogenic mutants G2019S and I2020T displayed significantly altered auto-phosphorylation. We observed an induction of detergent-insoluble high molecular weight structures upon expression of pathogenic LRRK2 mutants, but not the other LRRK2 variants. In contrast, each of the variants tested induced apoptotic death of cultured neurons similar to pathogenic LRRK2 in a FADD-dependent manner.
Overall, despite differences in some properties of LRRK2 function such as kinase activity and its oligomerization, each of the LRRK2 variants examined induced neuronal death to a similar extent. Furthermore, our findings further strengthen the notion of a convergence on the extrinsic cell death pathway common to mutations in LRRK2 that are capable of inducing neuronal death.
尽管LRRK2存在大量序列变异,但只有少数变异与帕金森病(PD)明确相关。即使在这组致病突变中,表型特征也可能有很大差异。
我们研究了在细胞模型中过表达希腊PD患者中描述的三种序列变异的LRRK2行为的多种特性,并与几种已知的致病和非致病LRRK2突变进行比较,以确定是否能在其他基于临床和/或遗传数据单独判断致病性不明确的较少见序列变异中观察到与致病LRRK2相关的特定表型。
在过表达LRRK2的HEK293T细胞中评估其寡聚化、活性、磷酸化以及与FADD的相互作用;通过量化瞬时表达LRRK2的原代神经元中的凋亡核来确定神经元死亡的诱导情况。
一种LRRK2变异体A211V的激酶活性有适度增加,而只有致病突变体G2019S和I2020T表现出明显改变的自磷酸化。我们观察到致病LRRK2突变体表达时会诱导去污剂不溶性高分子量结构的形成,而其他LRRK2变异体则不会。相反,所测试的每种变异体都以FADD依赖的方式诱导培养神经元的凋亡死亡,类似于致病LRRK2。
总体而言,尽管LRRK2功能的某些特性如激酶活性及其寡聚化存在差异,但所检测的每种LRRK2变异体在相似程度上诱导神经元死亡。此外,我们的研究结果进一步强化了这样一种观念,即能够诱导神经元死亡的LRRK2突变在细胞外死亡途径上存在趋同现象。